Ten Things to Know About Biologics & Biosimilars
Biologic drugs are disease-modifying anti-inflammatory drugs that help slow or stop the over-active inflammation that damages joints and organs in autoimmune, inflammatory diseases, like rheumatoid arthritis, juvenile arthritis, ankylosing spondylitis, psoriatic arthritis and others. A biosimilars is a type of biologic that is highly similar to and has no meaningful clinical difference from its "reference product," or original biologic.
A number of new biologics and biosimilars that treat arthritis are expected to arrive in 2023. Here's what you need to know about them. If you're thinking about beginning or switching to a new biologic or biosimilar, read the Questions to Ask Your Doctor About Biologics & Biosimilars. Made possible by the generous sponsors recognized below the graphic.
Click the image below to enlarge & download a pdf.
The content of this editorial was developed independently by the Arthritis Foundation, with support from the following sponsors: